STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
BCYC BICYCLE THERAPEUTICS PUBLIC LIMITED COMPANY StockScouter® Report
4
StockScouter® Score
BICYCLE THERAPEUTICS PUBLIC LIMITED COMPANY, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Short-term relative price momentum exhibits meaningful strength. Postive
- One or more less experienced analysts has modestly increased quarterly earnings estimates for BCYC. Positive/Neutral
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
B
D
F
C